Fact checked byRichard Smith

Read more

September 22, 2022
1 min read
Save

DELIVER

Fact checked byRichard Smith
You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Dapagliflozin (Farxiga, AstraZeneca) vs. placebo in patients with HF and ejection fraction above 40%.